Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P33527 (
ABCC1
)
1,164
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Multidrug resistance (MDR) is the major cause of cancer treatment failure. The ATP-binding cassette-B1 (ABCB1) transporter, also known as MDR1 or P-glycoprotein, is thought to promote the efflux of drugs from cells. MDR is also associated with the multidrug resistance-associated protein 1 (
ABCC1
) and the lung resistance-related protein (LRP), a human major vault protein. Moreover, MDR has a complex relationship with lipids. The ABCB1 has been reported to modulate cellular cholesterol homeostasis. Conversely, cholesterol has been reported to modulate multidrug transporters. However, results reported to date are contradictory and confusing. The aim of this study was to investigate whether LDL,
HDL
, and serum deprivation could influence ABCB1,
ABCC1
, and LRP expression in a human doxorubicin-resistant uterine sarcoma cell line. ABCB1 and
ABCC1
expression increased after 24 h of serum deprivation, and expression returned to basal levels after 72 h. LDL, depending on concentration, increased ABCB1,
ABCC1
, and LRP expression. ABCB1 expression increased at low
HDL
, and decreased at high
HDL
concentrations. We demonstrated that serum deprivation and lipoproteins, particularly LDL, modulated ABCB1 expression and, to a lesser extent,
ABCC1
expression. This finding may link the phenomena of drug transport, cholesterol metabolism and cancer.
...
PMID:ABCB1, ABCC1, and LRP gene expressions are altered by LDL, HDL, and serum deprivation in a human doxorubicin-resistant uterine sarcoma cell line. 2560 48
Sphingosine-1-phosphate (S1P) is a bioactive lipid implicated in e.g. angiogenesis, lymphocyte trafficking, and endothelial barrier function. Erythrocytes are a main source of plasma S1P together with platelets and endothelial cells. Apolipoprotein M (apoM) in
HDL
carries 70% of plasma S1P, whereas 30% is carried by albumin. The current aim was to investigate the role of apoM in export of S1P from human erythrocytes. Erythrocytes exported S1P more efficiently to
HDL
than to albumin, particularly when apoM was present in
HDL
. In contrast, export of sphingosine to
HDL
was unaffected by the presence of apoM. The specific ability of apoM to promote export of S1P was independent of apoM being bound in
HDL
particles. Treatment with MK-571, an inhibitor of the
ABCC1
transporter, effectively reduced export of S1P from human erythrocytes to apoM, whereas the export was unaffected by inhibitors of ABCB1 or ATPase. Thus,
ABCC1
could be involved in export of S1P from erythrocytes to apoM.
...
PMID:Apolipoprotein M mediates sphingosine-1-phosphate efflux from erythrocytes. 2911 54